🇺🇸#акции #сша #premarket
премаркет США - акции - заметные движения:
ВВЕРХ
#VIVE +23% Viveve Medical, Inc. - after falling 11% on Monday.
#OCGN +17% Ocugen Inc
#SPI +13% SPI Energy Co., Ltd. - after the company reported the sale of Sun Roof II and Sun Roof V solar projects in Italy.
#GERN +11% Geron Corporation - after the company disclosed that it has received an FDA Fast Track designation for Imetelstat for relapsed/refractory myelofibrosis.
#CABT +7% Catabasis Pharmaceuticals, Inc. - after the company disclosed that the Phase 3 PolarisDMD trial of edasalonexent in Duchenne Muscular Dystrophy has exceeded target enrollment.
#NLNK +7% NewLink Genetics Corporation - after announcing it has entered a merger agreement with Lumos Pharma to form a biopharmaceutical company focused on developing therapies to treat rare diseases.
#ADI +6% Analog Devices, Inc. - KeyBanc upgraded Analog Devices from Sector Weight to Overweight and announced a $130 price target.
#MNK +6% Mallinckrodt plc - after the company reported findings from its observational registry assessing Acthar Gel in MS relapse patients. The results were 'highly statistically significant' for all the efficacy endpoints.
#SNCR +5% Synchronoss Technologies, Inc.
#SFIX +4% Stitch Fix, Inc. - expected to release quarterly earnings after the closing bell.
#SDRL +4% Seadrill Limited
#EXK +4% Endeavour Silver Corp. - after dropping 9% on Monday.
#EYE +4% National Vision Holdings, Inc.
#LAIX +4% LAIX Inc.
#ENDP +3% Endo International plc
#UNFI +3% United Natural Foods, Inc. -ahead of quarterly earnings.
#SBGL +3% Sibanye Gold Limited
ВНИЗ
#GNFT -10% Genfit SA -after rising 8% on Monday.
#ANAB -10% AnaptysBio, Inc. - after reporting topline data from interim analyst of GALLOP phase 2 clinical trial of ANB019 monotherapy in moderate-to-severe generalized pustular psoriasis.
#REED -9% Reed's, Inc. - after the company issued weak preliminary third-quarter sales guidance. The company also announced Chairman John Belo will serve as interim CEO.
#HXL -4% Hexcel Corporation
#RELX -4% RELX PLC
#ECA -3% Encana Corporation
#TTM -3% Tata Motors Limited
#SLCA -3% U.S. Silica Holdings, Inc.
#GLPG -2% Galapagos NV
премаркет США - акции - заметные движения:
ВВЕРХ
#VIVE +23% Viveve Medical, Inc. - after falling 11% on Monday.
#OCGN +17% Ocugen Inc
#SPI +13% SPI Energy Co., Ltd. - after the company reported the sale of Sun Roof II and Sun Roof V solar projects in Italy.
#GERN +11% Geron Corporation - after the company disclosed that it has received an FDA Fast Track designation for Imetelstat for relapsed/refractory myelofibrosis.
#CABT +7% Catabasis Pharmaceuticals, Inc. - after the company disclosed that the Phase 3 PolarisDMD trial of edasalonexent in Duchenne Muscular Dystrophy has exceeded target enrollment.
#NLNK +7% NewLink Genetics Corporation - after announcing it has entered a merger agreement with Lumos Pharma to form a biopharmaceutical company focused on developing therapies to treat rare diseases.
#ADI +6% Analog Devices, Inc. - KeyBanc upgraded Analog Devices from Sector Weight to Overweight and announced a $130 price target.
#MNK +6% Mallinckrodt plc - after the company reported findings from its observational registry assessing Acthar Gel in MS relapse patients. The results were 'highly statistically significant' for all the efficacy endpoints.
#SNCR +5% Synchronoss Technologies, Inc.
#SFIX +4% Stitch Fix, Inc. - expected to release quarterly earnings after the closing bell.
#SDRL +4% Seadrill Limited
#EXK +4% Endeavour Silver Corp. - after dropping 9% on Monday.
#EYE +4% National Vision Holdings, Inc.
#LAIX +4% LAIX Inc.
#ENDP +3% Endo International plc
#UNFI +3% United Natural Foods, Inc. -ahead of quarterly earnings.
#SBGL +3% Sibanye Gold Limited
ВНИЗ
#GNFT -10% Genfit SA -after rising 8% on Monday.
#ANAB -10% AnaptysBio, Inc. - after reporting topline data from interim analyst of GALLOP phase 2 clinical trial of ANB019 monotherapy in moderate-to-severe generalized pustular psoriasis.
#REED -9% Reed's, Inc. - after the company issued weak preliminary third-quarter sales guidance. The company also announced Chairman John Belo will serve as interim CEO.
#HXL -4% Hexcel Corporation
#RELX -4% RELX PLC
#ECA -3% Encana Corporation
#TTM -3% Tata Motors Limited
#SLCA -3% U.S. Silica Holdings, Inc.
#GLPG -2% Galapagos NV
🇺🇸#premarket #сша
премаркет США - акции - заметные движения:
ВВЕРХ
#NAVB +65% Navidea Biopharmaceuticals, Inc. - reported results of second interim analysis of ongoing Phase 2B study in rheumatoid arthritis.
#TTPH +48% Tetraphase Pharmaceuticals, Inc. - announced determination of superior offer from Melinta Therapeutics, Inc.
#SNDL +26% Sundial Growers Inc. - after gaining over 9% on Thursday.
#NTEC +15% Intec Pharma Ltd. - after jumping 23% on Thursday.
#TTOO +15% T2 Biosystems, Inc.
#BLIN +13% Bridgeline Digital, Inc.
#DKL +9% Delek Logistics Partners, LP
#ENTX +8% Entera Bio Ltd. - shares tumbled 27% on Thursday as the company announced interim limited biomarker data from the ongoing Phase 2 clinical trial of EB613 in osteoporosis patients, with the study demonstrating statistically significant effects on the P1NP biomarker after one month of treatment as compared to placebo, and meaningful increases at months two and three as compared to placebo with the highest EB613 dose of 1.5mg.
#ONCY +7% Oncolytics Biotech Inc. -after declining 5% on Thursday.
#PAWN +7% Palo Alto Networks Inc - reported better-than-expected Q3 results. The company also issued FY20 guidance above estimates.
#CNAT +7% Conatus Pharmaceuticals Inc. -after declining 13% on Thursday.
#CLNS +7% Celsion Corporation -after jumping over 36% on Thursday.
#A +5% Agilent Technologies Inc - reported better-than-expected Q2 results.
#BKE +4% Buckle Inc - following Q1 results.
ВНИЗ
#SNDX -20% Syndax Pharmaceuticals, Inc. - reported receipt of final results from Phase 3 E2112 trial of entinostat plus exemestane in patients with HR+, HER2- breast cancer. The trial did not achieve primary endpoint.
#GERN -19% Geron Corporation - announced a proposed public offering of common stock and warrants..
#AKTX -15% Akari Therapeutics, Plc - on Thursday, Akari Therapeutics received positive EMA opinion on orphan designation for nomacopan for bullous pemphigoid.
#PDSB -14% PDS Biotechnology Corporation -after surging 17% on Thursday.
#SONM -13% Sonim Technologies, Inc. - after rising 15% on Thursday.
#XTNT -13% Xtant Medical Holdings, Inc. - after jumping 160% on Thursday.
#HOTH -13% Hoth Therapeutics, Inc. - priced underwritten public offering of 1.8 million shares at $2.75 per share.
#LSCC -12% Lattice Semiconductor Corporation
#CFRX -10% ContraFect Corp - announced a proposed public offering of common stock and warrants.
#IMAB -10% I-Mab - I-Mab and Genexine reported China NMPA clearance for Phase 2 clinical trial of TJ107/HyLeukin-7 in glioblastoma multiforme.
#MPWR -9% Monolithic Power Systems, Inc.
#MXL -9% MaxLinear, Inc. - after dropping over 6% on Thursday.
#DVAX -8% Dynavax Technologies Corporation - announced a proposed public offering of common stock.
#NNDM -6% Nano Dimension Ltd.
#HPE -5% Hewlett Packard Enterprise Co - reported weaker-than-expected Q2 results.
#GDS -5% GDS Holdings Limited - after declining over 5% on Thursday.
премаркет США - акции - заметные движения:
ВВЕРХ
#NAVB +65% Navidea Biopharmaceuticals, Inc. - reported results of second interim analysis of ongoing Phase 2B study in rheumatoid arthritis.
#TTPH +48% Tetraphase Pharmaceuticals, Inc. - announced determination of superior offer from Melinta Therapeutics, Inc.
#SNDL +26% Sundial Growers Inc. - after gaining over 9% on Thursday.
#NTEC +15% Intec Pharma Ltd. - after jumping 23% on Thursday.
#TTOO +15% T2 Biosystems, Inc.
#BLIN +13% Bridgeline Digital, Inc.
#DKL +9% Delek Logistics Partners, LP
#ENTX +8% Entera Bio Ltd. - shares tumbled 27% on Thursday as the company announced interim limited biomarker data from the ongoing Phase 2 clinical trial of EB613 in osteoporosis patients, with the study demonstrating statistically significant effects on the P1NP biomarker after one month of treatment as compared to placebo, and meaningful increases at months two and three as compared to placebo with the highest EB613 dose of 1.5mg.
#ONCY +7% Oncolytics Biotech Inc. -after declining 5% on Thursday.
#PAWN +7% Palo Alto Networks Inc - reported better-than-expected Q3 results. The company also issued FY20 guidance above estimates.
#CNAT +7% Conatus Pharmaceuticals Inc. -after declining 13% on Thursday.
#CLNS +7% Celsion Corporation -after jumping over 36% on Thursday.
#A +5% Agilent Technologies Inc - reported better-than-expected Q2 results.
#BKE +4% Buckle Inc - following Q1 results.
ВНИЗ
#SNDX -20% Syndax Pharmaceuticals, Inc. - reported receipt of final results from Phase 3 E2112 trial of entinostat plus exemestane in patients with HR+, HER2- breast cancer. The trial did not achieve primary endpoint.
#GERN -19% Geron Corporation - announced a proposed public offering of common stock and warrants..
#AKTX -15% Akari Therapeutics, Plc - on Thursday, Akari Therapeutics received positive EMA opinion on orphan designation for nomacopan for bullous pemphigoid.
#PDSB -14% PDS Biotechnology Corporation -after surging 17% on Thursday.
#SONM -13% Sonim Technologies, Inc. - after rising 15% on Thursday.
#XTNT -13% Xtant Medical Holdings, Inc. - after jumping 160% on Thursday.
#HOTH -13% Hoth Therapeutics, Inc. - priced underwritten public offering of 1.8 million shares at $2.75 per share.
#LSCC -12% Lattice Semiconductor Corporation
#CFRX -10% ContraFect Corp - announced a proposed public offering of common stock and warrants.
#IMAB -10% I-Mab - I-Mab and Genexine reported China NMPA clearance for Phase 2 clinical trial of TJ107/HyLeukin-7 in glioblastoma multiforme.
#MPWR -9% Monolithic Power Systems, Inc.
#MXL -9% MaxLinear, Inc. - after dropping over 6% on Thursday.
#DVAX -8% Dynavax Technologies Corporation - announced a proposed public offering of common stock.
#NNDM -6% Nano Dimension Ltd.
#HPE -5% Hewlett Packard Enterprise Co - reported weaker-than-expected Q2 results.
#GDS -5% GDS Holdings Limited - after declining over 5% on Thursday.